Delta opioid peptide DADLE and naltrexone cause cell cycle arrest and differentiation in a CNS neural progenitor cell line

Synapse

Volumn 64, Issue 4, 2010, Pages 267-273

  Tsai, Shang Y I ^a   Lee, Chung Ting ^b   Hayashi, Teruo ^a   Freed, William J ^b   Su, Tsung Ping ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

AF5; DADLE; Delta opioid; Differentiation; Dopamine (DA); Naltrexone

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; NALTREXONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH INHIBITION; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENKEPHALIN, LEUCINE-2-ALANINE; FLOW CYTOMETRY; IN SITU NICK-END LABELING; NALTREXONE; NEURONS; RATS; STEM CELLS; TIME FACTORS; TUBULIN;

EID: 73449125886     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20727     Document Type: Article

References (19)

1. Borlongan CV, Su TP, Wang Y. 2000. Treatment with delta opioid peptide enhances in vitro and in vivo survival of rat dopaminergic neurons. Neuroreport 11:923-926.
2. Calegari F, Huttner WB. 2003. An inhibition of cyclin-dependent kinases that lengthens, but does not arrest, neuroepithelial cell cycle induces premature neurogenesis. J Cell Sci 116:4947-4955.
3. Hayashi T, Tsao LI, Su TP. 2002. Antiapoptotic and cytotoxic properties of delta opioid peptide [D-Ala(2),D-Leu(5)]enkephalin in PC12 cells. Synapse 43:86-94.
4. Hodge RD, D'Ercole AJ, O'Kusky JR. 2004. Insulin-like growth factor-I accelerates the cell cycle by decreasing G1 phase length and increases cell cycle reentry in the embryonic cerebral cortex. J Neurosci 24:10201-10210.
5. Ilyinsky OB, Kozlova MV, Kondrikova ES, Kalentchuk VU, Titov MI, Bespalova ZD. 1987. Effects of opioid peptides and naloxone on nervous tissue in culture. Neuroscience 22:719-735.
6. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, Nishikawa SI, Sasai Y. 2000. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28:31-40.
7. Kim HJ, Hida H, Jung CG, Miura Y, Nishino H. 2006. Treatment with deferoxamine increases neurons from neural stem/progenitor cells. Brain Res 1092:1-15.
8. Kornyei JL, Vertes Z, Kovacs KA, Gocze PM, Vertes M. 2003. Developmental changes in the inhibition of cultured rat uterine cell proliferation by opioid peptides. Cell Prolif 36:151-163.
9. Kozlova M, Kalentchuk V. 1994. Stimulatory effect of opioid peptides and naloxone on rat spinal cord cells in primary dissociated culture. Int J Dev Neurosci 12:507-515.
10. Lukaszewicz A, Savatier P, Cortay V, Kennedy H, Dehay C. 2002. Contrasting effects of basic fibroblast growth factor and neurotrophin 3 on cell cycle kinetics of mouse cortical stem cells. J Neurosci 22:6610-6622.
11. Martin-Kleiner I. 2002. The effect of opioid agonists of delta-class DSLET, mu-class DAMGO, kappa-class U-69593 and an opioid antagonist, naloxone, on MTT activity of NALM-1 leukemic cells. Biomed Pharmacother 56:458-462.
12. McLaughlin PJ, Levin RJ, Zagon IS. 2003. Opioid growth factor (OGF) inhibits the progression of human squamous cell carcinoma of the head and neck transplanted into nude mice. Cancer Lett 199:209-217.
13. Misumi S, Kim TS, Jung CG, Masuda T, Urakawa S, Isobe Y, Furuyama F, Nishino H, Hida H. 2008. Enhanced neurogenesis from neural progenitor cells with G1/S-phase cell cycle arrest is mediated by transforming growth factor beta1. Eur J Neurosci 28:1049-1059.
14. Persson AI, Thorlin T, Bull C, Eriksson PS. 2003b. Opioid-induced proliferation through the MAPK pathway in cultures of adult hippocampal progenitors. Mol Cell Neurosci 23:360-372.
15. Persson AI, Thorlin T, Bull C, Zarnegar P, Ekman R, Terenius L, Eriksson PS. 2003a. Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors. Eur J Neurosci 17:1159-1172.
16. Sanchez JF, Crooks DR, Lee CT, Schoen CJ, Amable R, Zeng X, Florival-Victor T, Morales N, Truckenmiller ME, Smith DR, Freed WJ. 2006. GABAergic lineage differentiation of AF5 neural progenitor cells in vitro. Cell Tissue Res 324:1-8.
17. Truckenmiller ME, Vawter MP, Zhang P, Conejero-Goldberg C, Dillon-Carter O, Morales N, Cheadle C, Becker KG, Freed WJ. 2002. AF5, a CNS cell line immortalized with an N-terminal fragment of SV40 large T: Growth, differentiation, genetic stability, and gene expression. Exp Neurol 175:318-337.
18. Tsao LI, Hayashi T, Su TP. 2000. Blockade of dopamine transporter and tyrosine hydroxylase activity loss by [D-Ala(2), D -Leu(5)]enkephalin in methamphetamine-treated CD-1 mice. Eur J Pharmacol 404:89-93.
19. Zagon IS, McLaughlin PJ. 2003. Opioids and the apoptotic pathway in human cancer cells. Neuropeptides 37:79-88.